Trading Signals: HTBX Stock Price Prediction and Forecast (Mon. Dec. 28, 2015 - Mon. May. 2, 2022)(Heat Biologics, Inc.)
| HTBX latest price $2.4400 (-1.21%) ($2.4000 - $2.4900) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.08% (three month average) | RSI | 31 | Latest Price | $2.4400(-1.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HTBX declines -5.1% a day on average for past five trading days. | Weekly Trend | HTBX declines -6.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HTBX advance at 0% a week (0% probability) IVW(86%) OIH(79%) XOP(74%) SMH(70%) IWF(64%) | Factors Impacting HTBX price | HTBX will decline at least -2.54% in a week (0% probabilities). SHY(-42%) BWX(-39%) BND(-23%) IGOV(-22%) XLP(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.54% (StdDev 5.08%) | Hourly BBV | -1.1 () | Intraday Trend | -1.6% | | | |
|
1 - 5 Day Possible Target | $-11.21(-559.43%) | Resistance Level | $2.85 | 5 Day Moving Average | $2.59(-5.79%) | 10 Day Moving Average | $2.71(-9.96%) | 20 Day Moving Average | $2.85(-14.39%) | To recent high | -22.5% | To recent low | 16.2% | Market Cap | $268m | | | | Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC. |